Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths

SM Ueda, DS Kapp, MK Cheung, JY Shin… - American journal of …, 2008 - Elsevier
OBJECTIVE: The purpose of this study was to determine factors responsible for the
increasing number of deaths from corpus cancer over three time periods. STUDY DESIGN …

[HTML][HTML] Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas

SM Ueda, KL Yap, B Davidson, Y Tian, V Murthy… - Journal of …, 2010 - hindawi.com
Our previous reports demonstrated that NAC1, a BTB/POZ domain-containing nuclear
protein, upregulates in recurrent ovarian serous carcinoma and participates in developing …

[PDF][PDF] Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?

JK Chan, SM Ueda, VE Sugiyama, CD Stave… - Journal of clinical …, 2008 - Citeseer
Purpose To identify the characteristics of phase II studies that predict for subsequent
“positive” phase III trials (those that reached the proposed primary end points of study or …

Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer

X Yu, D Lum, TK Kiet, KC Fuh, J Orr Jr… - Journal of surgical …, 2013 - Wiley Online Library
Abstract Background and Objectives To analyze the utilization and hospital charges
associated with robotic (RS) versus laparoscopic (LS) versus open surgery (OS) in …

ADXS11-001 immunotherapy in squamous or non-squamous persistent/recurrent metastatic cervical cancer: Results from stage I of the phase II GOG/NRG0265 study.

WK Huh, DS Dizon, MA Powell, CA Leath, LM Landrum… - 2016 - ascopubs.org
5516 Background: There is no approved treatment with a survival benefit for
persistent/recurrent metastatic cervical cancer (PRmCC) patients (pts) who have progressed …

Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival

RL Giuntoli, MA Gerardi, AV Yemelyanova… - International Journal of …, 2012 - ijgc.bmj.com
Objective The aim of this study was to determine if comprehensive surgical staging is a
better predictor of outcome than incomplete staging for women with stage I noninvasive or …

Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype

ME Skaznik-Wikiel, SM Ueda, HE Frasure, PG Rose… - Acta cytologica, 2011 - karger.com
Objective: Early detection of uterine papillary serous (UPSC), clear cell (CCC), and grade 3
endometrioid carcinomas (G3EC)–all poor prognostic variants of endometrial carcinoma …

Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature

JN Barlin, SM Ueda, RE Bristow - Women's Health, 2009 - journals.sagepub.com
There is no standard approach to managing women with advanced or recurrent endometrial
cancer; however, there is increasing evidence to support a role for cytoreductive surgery in …

Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93

SM Ueda, TL Mao, FP Kuhajda, C Vasoontara… - The American journal of …, 2009 - Elsevier
Fatty acid synthase (FASN) is an emerging tumor-associated marker and a promising
antitumor therapeutic target. In this study, we analyzed the expression of FASN in normal …

Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive …

LS Krill, SM Ueda, M Gerardi, RE Bristow - Gynecologic oncology, 2011 - Elsevier
OBJECTIVE: To evaluate the risk of postoperative complications related to HA-CMC use in
patients undergoing optimal cytoreductive surgery for primary and recurrent ovarian …